[1]
Oblitas, C.-M., Galeano-Valle, F., La Cruz, L.V.-D., Toro-Cervera, J.D. and Demelo-Rodríguez, P. 2019. Omalizumab as a Provoking Factor for Venous Thromboembolism. Drug Target Insights. 13, 1 (Jul. 2019). DOI:https://doi.org/10.33393/dti.2019.1415.